Insiders and Billionaire Leon Cooperman Like American International Group Inc (AIG) and More

Express Scripts Holding Company (NASDAQ:ESRX) was another common pick between at least one insider and Cooperman’s fund- specifically, the 13F showed a position of 2.7 million shares. With the company recovering nicely from its dispute with Walgreen Company (NYSE:WAG), earnings per share are expected to come in at $4.30 this year which would place the pharmacy benefit management company at a current-year P/E of 14. Wall Street analysts expect small increases in earnings after that, so Express Scripts Holding Company (NASDAQ:ESRX) could be a value play. Bain Capital’s long/short equity hedge fund Brookside Capital had 3.9 million shares in its portfolio according to that fund’s own 13F (research more stocks Brookside owned).

Between January and March, Cooperman and his team slightly increased their stake in SandRidge Energy Inc. (NYSE:SD) to a total of nearly 27 million shares. We’ve also tracked an insider purchase at the troubled natural gas producer, where low nat gas prices following the company’s rapid expansion in recent years have left analysts expecting net losses both this year and in 2014. The stock has fallen 18% in the last year, yet 15% of the float is still held short. Prem Watsa’s Fairfax Financial Holdings is another major shareholder in SandRidge Energy Inc. (NYSE:SD) (find Watsa’s favorite stocks).

Rounding out our list of stocks from Omega’s 13F with recent insider purchases is medical device company Boston Scientific Corporation (NYSE:BSX). Boston Scientific Corporation (NYSE:BSX) has also been a bit troubled recently, and in the first quarter of 2013 its revenue fell by 6% versus a year earlier. Markets are expecting the company to rebound strongly, judging by the fact that it is valued at 20 times forward earnings estimates. Renaissance Technologies, founded by billionaire Jim Simons, increased its holdings during Q1 to 8.4 million shares (see Renaissance’s stock picks) but we would still avoid it for now on valuation.

Disclosure: I own no shares of any stocks mentioned in this article.